Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

The Unfolding Legal Landscape: Jardiance and Its Alleged Connection to Fournier’s Gangrene

Introduction 

Understanding the legal intricacies surrounding a lawsuit is crucial, particularly when it involves a serious matter like Fournier’s gangrene allegedly linked to the usage of Jardiance. This article aims to shed light on the recent developments in the ongoing litigation, providing clear and succinct insights into the latest legal landscape.  

Background 

Jardiance (empagliflozin) is a popular drug developed by Boehringer Ingelheim and Eli Lilly and Company. It’s primarily used in the management of type 2 diabetes. Since its release, it has been widely prescribed worldwide due to effectiveness in reducing cardiovascular deaths. [1]

However, in more recent years, legal concerns have arisen about a supposed linkage between Jardiance and the development of a rare but life-threatening infection known as Fournier’s gangrene[2]

Understanding Fournier’s Gangrene 

Fournier’s gangrene is a necrotizing infection affecting the genital or perineal regions. It is a rare disease but can quickly progress from minor symptoms to life-threatening conditions if left untreated. The most crucial aspect of this infection that spiked legal interest is its alleged connection with Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors such as Jardiance. [3]

Conclusion 

The unfolding litigation surrounding Jardiance and its alleged link with Fournier’s gangrene highlights the complex interface between medical treatments, risks disclosure, and legal implications thereof. As always, the health and safety of patients remain paramount, and it is crucial that regulatory entities and manufacturers continue to strive to ensure transparency and the delivery of critical safety information to patients. Legal precedents set by these cases could shape future regulatory practices, further stressing the importance of ongoing monitoring and assessment of pharmaceutical interventions. 

If you or a loved one has suffered an injury from Jardiance, give us a call at the Michael Brady Lynch Firm at 888-585-5970 or brandon@mblynchfirm.com. 

Date: August 15, 2023

Author: Brandon Salter

Citations

[1] https://www.boehringer-ingelheim.com/us/press-release/us-fda-approves-jardiance-empagliflozin-treat-adults-living-heart-failure-reduced

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368210/

[3] https://my.clevelandclinic.org/health/diseases/22025-fourniers-gangrene

Injured on a Cruise Ship? Call Us

Injured on a Cruise Ship? Call Us

Cruise vacations promise relaxation and adventure, but accidents do happen. Injuries aboard cruise ships can range from minor incidents to severe accidents, raising complicated legal questions about liability and compensation.

read more
Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
×
What Our Clients Are Saying